Effect of BL-21 (Wei-Yu) acupoint stimulation on gastric motility following preanesthetic treatment in dogs.
In acupuncture practice of animals, preanesthetics sometimes are needed. The purpose of this study was to select the ideal chemical restraint at acupuncture for gastric motility. Nine healthy mixed breed dogs weighed 10-21 kg and aged 1-3 years old were used in this study. Two EMG surface electrodes were placed between the seromuscular and the mucosal layer of pylorus. Twenty minutes after feeding normal gastric motility was recorded for 60 minutes using physiograph (Narco-Biosystem). Then preanesthetic treated-gastric motility was observed for 30 minutes. Preanesthetics used were xylazine, diazepam, and acepromazine. Acupuncture needles were inserted to BL-21 (Wei-Yu) acupoint, and then changes of gastric motility were recorded for 60 minutes. The gastric motility following xylazine administration (1 mg/kg, IV) was markedly decreased. BL-21 (Wei-Yu) acupoints stimulation did not alter xylazine-induced depression of gastric motility. The diazepam (1 mg/kg IV) treated-gastric motility was increased mildly 20 minutes after drug administration. BL-21 (Wei-Yu) acupoint stimulation after diazepam administration enhanced gastric motility significantly. The gastric motility following acepromazine (0.3 mg/kg, IM) administration was not changed compared with normal gastric motility. Application of traditional acupuncture at BL-21 (Wei-Yu) significantly increased the gastric motility. Based on these results, acepromazine and diazepam could be acceptable chemical restraints for acupuncture therapy of gastric motility, but xylazine couldn't be.
Kim
H Y
HY
Department of Veterinary Surgery, College of Veterinary Medicine, Seoul National University, Seoul 151-742, Korea.
Kwon
O K
OK
Nam
T C
TC
D000075:Acepromazine; D026881:Acupuncture / Q000592:standards*; D015669:Acupuncture Points; D000759:Adjuvants, Anesthesia; D000316:Adrenergic alpha-Agonists; D000818:Animals; D014150:Antipsychotic Agents; D001285:Atropine; D003975:Diazepam; D004285:Dogs / Q000502:physiology*; D018492:Dopamine Antagonists; D004576:Electromyography / Q000662:veterinary; D005769:Gastrointestinal Motility / Q000187:drug effects / Q000502:physiology*; D006993:Hypnotics and Sedatives; D008787:Metoclopramide; D010276:Parasympatholytics; D011229:Preanesthetic Medication / Q000592:standards / Q000662:veterinary*; D014991:Xylazine
D000759:Adjuvants, Anesthesia; D000316:Adrenergic alpha-Agonists; D014150:Antipsychotic Agents; D018492:Dopamine Antagonists; D006993:Hypnotics and Sedatives; D010276:Parasympatholytics; D014991:Xylazine; D000075:Acepromazine; D001285:Atropine; D008787:Metoclopramide; D003975:Diazepam